As of 2025-07-10, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (39.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.90 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -457.9%.
The range of the Relative Valuation is (25.79) - (50.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 26.9x | 20.1x |
| Forward P/E multiples | 13.8x - 29.5x | 21.6x |
| Fair Price | (25.79) - (50.27) | (39.01) |
| Upside | -336.6% - -561.2% | -457.9% |
| Date | P/E |
| 2025-07-03 | -5.78 |
| 2025-07-02 | -5.70 |
| 2025-07-01 | -5.43 |
| 2025-06-30 | -5.43 |
| 2025-06-27 | -5.52 |
| 2025-06-26 | -5.62 |
| 2025-06-25 | -5.47 |
| 2025-06-24 | -5.61 |
| 2025-06-23 | -5.35 |
| 2025-06-20 | -4.98 |
| 2025-06-18 | -4.93 |
| 2025-06-17 | -4.83 |
| 2025-06-16 | -5.04 |
| 2025-06-13 | -5.15 |
| 2025-06-12 | -5.17 |
| 2025-06-11 | -5.02 |
| 2025-06-10 | -5.22 |
| 2025-06-09 | -5.28 |
| 2025-06-06 | -4.99 |
| 2025-06-05 | -4.90 |
| 2025-06-04 | -4.86 |
| 2025-06-03 | -4.49 |
| 2025-06-02 | -4.53 |
| 2025-05-30 | -4.37 |
| 2025-05-29 | -4.26 |
| 2025-05-28 | -3.19 |
| 2025-05-27 | -3.09 |
| 2025-05-23 | -3.40 |
| 2025-05-22 | -3.18 |
| 2025-05-21 | -3.14 |
| 2025-05-20 | -3.03 |
| 2025-05-19 | -2.75 |
| 2025-05-16 | -2.53 |
| 2025-05-15 | -2.54 |
| 2025-05-14 | -2.60 |
| 2025-05-13 | -2.84 |
| 2025-05-12 | -2.89 |
| 2025-05-09 | -2.72 |
| 2025-05-08 | -2.85 |
| 2025-05-07 | -2.51 |
| 2025-05-06 | -2.70 |
| 2025-05-05 | -3.05 |
| 2025-05-02 | -3.03 |
| 2025-05-01 | -2.98 |
| 2025-04-30 | -3.06 |
| 2025-04-29 | -3.03 |
| 2025-04-28 | -2.72 |
| 2025-04-25 | -2.73 |
| 2025-04-24 | -2.78 |
| 2025-04-23 | -2.77 |